SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Pressure BioSciences, Inc. (PBIO) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 32/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — PBIO
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.01
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-1.51
Book Value / Share$0.00
Revenue / Share$0.08
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2014 |
$-13.20 |
$1.37M |
$-4.61M |
-335.5% |
| 2015 |
$-10.80 |
$1.8M |
$-7.42M |
-412.5% |
| 2016 |
$-3.00 |
$1.98M |
$-2.71M |
-137% |
| 2017 |
$-9.62 |
$2.24M |
$-10.72M |
-478.3% |
| 2018 |
$-15.33 |
$2.46M |
$-9.7M |
-394.6% |
| 2019 |
$-7.98 |
$1.81M |
$-11.66M |
-644.3% |
| 2020 |
$-5.32 |
$1.22M |
$-24.35M |
-1994.9% |
| 2021 |
$-3.42 |
$2M |
$-34.6M |
-1728.1% |
| 2022 |
$-1.61 |
$1.73M |
$-16.82M |
-972.9% |
| 2023 |
$-1.51 |
$1.98M |
$-29.31M |
-1482.2% |
